Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.410
-0.100 (-2.22%)
At close: Apr 2, 2026, 4:00 PM EDT
4.410
0.00 (0.00%)
After-hours: Apr 2, 2026, 7:00 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.51 billion as of April 2, 2026. Its market cap has increased by 127.76% in one year.
Market Cap
1.51B
Enterprise Value
1.07B
1-Year Change
127.76%
Ranking
Category
Stock Price
$4.41
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.51B, an increase of 766.52%. That is a compound annual growth rate of 47.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 1.55B | -49.67% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 1.62B |
| Recursion Pharmaceuticals | 1.62B |
| Nurix Therapeutics | 1.60B |
| Oculis Holding AG | 1.60B |
| Intellia Therapeutics | 1.57B |
| Immunocore Holdings | 1.54B |
| MBX Biosciences | 1.53B |
| Rapport Therapeutics | 1.51B |